SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 449.62 |
Enterprise Value ($M) | 350.00 |
Book Value ($M) | 551.84 |
Book Value / Share | 9.02 |
Price / Book | 0.81 |
NCAV ($M) | 534.39 |
NCAV / Share | 8.74 |
Price / NCAV | 0.84 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.60 |
Return on Assets (ROA) | -0.38 |
Return on Equity (ROE) | -0.42 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 10.02 |
Current Ratio | 10.02 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 604.99 |
Assets | 622.43 |
Liabilities | 70.60 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | 0.00 |
Net Income | 0.00 |
Earnings Per Share Basic And Diluted | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 0.00 |
Cash from Investing | 0.00 |
Cash from Financing | 0.00 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | Vanguard Group Inc | |||
13G/A | Bb Biotech Ag | |||
13D | Biogen Inc. | |||
13G/A | Fmr Llc | 8.63 | -16.36 | |
13G/A | BlackRock, Inc. | 8.80 | 0.00 | |
13G/A | State Street Corp | 4.80 | -25.32 | |
13G/A | Wellington Management Group Llp | 0.07 | -99.34 | |
13G | Rtw Investments, Lp | 8.70 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
126,867 | 1,370,790 | 9.26 | |
444,016 | 1,530,538 | 29.01 | |
174,773 | 1,788,274 | 9.77 | |
67,655 | 851,500 | 7.95 | |
497,570 | 3,699,885 | 13.45 | |
(click for more detail) |
Similar Companies | |
---|---|
RNAC – Cartesian Therapeutics, Inc. | RVNC – Revance Therapeutics, Inc. |
RYTM – Rhythm Pharmaceuticals, Inc. | SCYX – SCYNEXIS, Inc. |
SGMT – Sagimet Biosciences Inc. |
Financial data and stock pages provided by
Fintel.io